Empowered by Tyler Technologies
Refine Results

The population density of Rochester, NY was 5,896 in 2012. The population density of Providence, RI was 9,684 in 2012.

Population Density

Population Density is computed by dividing the total population by Land Area Per Square Mile.

Above charts are based on data from the U.S. Census American Community Survey | ODN Dataset | API - Notes:

1. ODN datasets and APIs are subject to change and may differ in format from the original source data in order to provide a user-friendly experience on this site.

2. To build your own apps using this data, see the ODN Dataset and API links.

3. If you use this derived data in an app, we ask that you provide a link somewhere in your applications to the Open Data Network with a citation that states: "Data for this application was provided by the Open Data Network" where "Open Data Network" links to http://opendatanetwork.com. Where an application has a region specific module, we ask that you add an additional line that states: "Data about REGIONX was provided by the Open Data Network." where REGIONX is an HREF with a name for a geographical region like "Seattle, WA" and the link points to this page URL, e.g. http://opendatanetwork.com/region/1600000US5363000/Seattle_WA

Geographic and Population Datasets Involving Providence, RI or Rochester, NY

  • API

    Monthly HELP (Highway Emergency Local Patrol) Assists: Beginning 2010

    data.ny.gov | Last Updated 2024-06-05T17:51:17.000Z

    The HELP (Highway Emergency Local Patrol) file provides the number of motorists assisted by month, by region, in vehicles traveling on over 1,450 miles of limited access interstate roadways, parkways, and expressways on Long Island, in New York City, the Lower Hudson Valley, Buffalo, Syracuse, Rochester, and the Albany Capital District.

  • API

    NYCHA Development Data Book

    data.cityofnewyork.us | Last Updated 2024-05-13T15:53:04.000Z

    Contains the main body of the "Development Data Book". The Development Data Book lists all of the Authority's Developments alphabetically and includes information on the development identification numbers, program and construction type, number of apartments and rental rooms, population, number of buildings and stories, street boundaries, and political districts.

  • API

    Key Credit Collection: Beginning 2010

    data.ny.gov | Last Updated 2024-08-06T12:03:02.000Z

    Quarterly snapshot of residential collection data submitted by New York State’s ten largest distribution utility companies.

  • API

    Rates of COVID-19 Cases or Deaths by Age Group and Vaccination Status

    data.cdc.gov | Last Updated 2023-07-20T16:01:58.000Z

    Data for CDC’s COVID Data Tracker site on Rates of COVID-19 Cases and Deaths by Vaccination Status. Click 'More' for important dataset description and footnotes Dataset and data visualization details: These data were posted on October 21, 2022, archived on November 18, 2022, and revised on February 22, 2023. These data reflect cases among persons with a positive specimen collection date through September 24, 2022, and deaths among persons with a positive specimen collection date through September 3, 2022. Vaccination status: A person vaccinated with a primary series had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after verifiably completing the primary series of an FDA-authorized or approved COVID-19 vaccine. An unvaccinated person had SARS-CoV-2 RNA or antigen detected on a respiratory specimen and has not been verified to have received COVID-19 vaccine. Excluded were partially vaccinated people who received at least one FDA-authorized vaccine dose but did not complete a primary series ≥14 days before collection of a specimen where SARS-CoV-2 RNA or antigen was detected. Additional or booster dose: A person vaccinated with a primary series and an additional or booster dose had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after receipt of an additional or booster dose of any COVID-19 vaccine on or after August 13, 2021. For people ages 18 years and older, data are graphed starting the week including September 24, 2021, when a COVID-19 booster dose was first recommended by CDC for adults 65+ years old and people in certain populations and high risk occupational and institutional settings. For people ages 12-17 years, data are graphed starting the week of December 26, 2021, 2 weeks after the first recommendation for a booster dose for adolescents ages 16-17 years. For people ages 5-11 years, data are included starting the week of June 5, 2022, 2 weeks after the first recommendation for a booster dose for children aged 5-11 years. For people ages 50 years and older, data on second booster doses are graphed starting the week including March 29, 2022, when the recommendation was made for second boosters. Vertical lines represent dates when changes occurred in U.S. policy for COVID-19 vaccination (details provided above). Reporting is by primary series vaccine type rather than additional or booster dose vaccine type. The booster dose vaccine type may be different than the primary series vaccine type. ** Because data on the immune status of cases and associated deaths are unavailable, an additional dose in an immunocompromised person cannot be distinguished from a booster dose. This is a relevant consideration because vaccines can be less effective in this group. Deaths: A COVID-19–associated death occurred in a person with a documented COVID-19 diagnosis who died; health department staff reviewed to make a determination using vital records, public health investigation, or other data sources. Rates of COVID-19 deaths by vaccination status are reported based on when the patient was tested for COVID-19, not the date they died. Deaths usually occur up to 30 days after COVID-19 diagnosis. Participating jurisdictions: Currently, these 31 health departments that regularly link their case surveillance to immunization information system data are included in these incidence rate estimates: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Idaho, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Nebraska, New Jersey, New Mexico, New York, New York City (New York), North Carolina, Philadelphia (Pennsylvania), Rhode Island, South Dakota, Tennessee, Texas, Utah, Washington, and West Virginia; 30 jurisdictions also report deaths among vaccinated and unvaccinated people. These jurisdictions represent 72% of the total U.S. population and all ten of the Health and Human Services Regions. Data on cases

  • API

    Biodiversity by County - Distribution of Animals, Plants and Natural Communities

    data.ny.gov | Last Updated 2022-02-25T19:45:56.000Z

    The NYS Department of Environmental Conservation (DEC) collects and maintains several datasets on the locations, distribution and status of species of plants and animals. Information on distribution by county from the following three databases was extracted and compiled into this dataset. First, the New York Natural Heritage Program biodiversity database: Rare animals, rare plants, and significant natural communities. Significant natural communities are rare or high-quality wetlands, forests, grasslands, ponds, streams, and other types of habitats. Next, the 2nd NYS Breeding Bird Atlas Project database: Birds documented as breeding during the atlas project from 2000-2005. And last, DEC’s NYS Reptile and Amphibian Database: Reptiles and amphibians; most records are from the NYS Amphibian & Reptile Atlas Project (Herp Atlas) from 1990-1999.

  • API

    Rates of COVID-19 Cases or Deaths by Age Group and Vaccination Status and Booster Dose

    data.cdc.gov | Last Updated 2023-06-09T00:47:32.000Z

    Data for CDC’s COVID Data Tracker site on Rates of COVID-19 Cases and Deaths by Vaccination Status. Click 'More' for important dataset description and footnotes Dataset and data visualization details: These data were posted on October 21, 2022, archived on November 18, 2022, and revised on February 22, 2023. These data reflect cases among persons with a positive specimen collection date through September 24, 2022, and deaths among persons with a positive specimen collection date through September 3, 2022. Vaccination status: A person vaccinated with a primary series had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after verifiably completing the primary series of an FDA-authorized or approved COVID-19 vaccine. An unvaccinated person had SARS-CoV-2 RNA or antigen detected on a respiratory specimen and has not been verified to have received COVID-19 vaccine. Excluded were partially vaccinated people who received at least one FDA-authorized vaccine dose but did not complete a primary series ≥14 days before collection of a specimen where SARS-CoV-2 RNA or antigen was detected. Additional or booster dose: A person vaccinated with a primary series and an additional or booster dose had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after receipt of an additional or booster dose of any COVID-19 vaccine on or after August 13, 2021. For people ages 18 years and older, data are graphed starting the week including September 24, 2021, when a COVID-19 booster dose was first recommended by CDC for adults 65+ years old and people in certain populations and high risk occupational and institutional settings. For people ages 12-17 years, data are graphed starting the week of December 26, 2021, 2 weeks after the first recommendation for a booster dose for adolescents ages 16-17 years. For people ages 5-11 years, data are included starting the week of June 5, 2022, 2 weeks after the first recommendation for a booster dose for children aged 5-11 years. For people ages 50 years and older, data on second booster doses are graphed starting the week including March 29, 2022, when the recommendation was made for second boosters. Vertical lines represent dates when changes occurred in U.S. policy for COVID-19 vaccination (details provided above). Reporting is by primary series vaccine type rather than additional or booster dose vaccine type. The booster dose vaccine type may be different than the primary series vaccine type. ** Because data on the immune status of cases and associated deaths are unavailable, an additional dose in an immunocompromised person cannot be distinguished from a booster dose. This is a relevant consideration because vaccines can be less effective in this group. Deaths: A COVID-19–associated death occurred in a person with a documented COVID-19 diagnosis who died; health department staff reviewed to make a determination using vital records, public health investigation, or other data sources. Rates of COVID-19 deaths by vaccination status are reported based on when the patient was tested for COVID-19, not the date they died. Deaths usually occur up to 30 days after COVID-19 diagnosis. Participating jurisdictions: Currently, these 31 health departments that regularly link their case surveillance to immunization information system data are included in these incidence rate estimates: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Idaho, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Nebraska, New Jersey, New Mexico, New York, New York City (New York), North Carolina, Philadelphia (Pennsylvania), Rhode Island, South Dakota, Tennessee, Texas, Utah, Washington, and West Virginia; 30 jurisdictions also report deaths among vaccinated and unvaccinated people. These jurisdictions represent 72% of the total U.S. population and all ten of the Health and Human Services Regions. Data on cases

  • API

    Short-term Industry Projections

    data.ny.gov | Last Updated 2024-03-06T19:36:11.000Z

    Short-term Industry Projections for a 2 year time horizon are provided for the state and 10 labor market regions to provide individuals and organizations with an industry outlook.

  • API

    Long-term Industry Projections

    data.ny.gov | Last Updated 2023-06-30T17:36:30.000Z

    Long-term Industry Projections for a 10 year time horizon are provided for the state and 10 labor market regions to provide individuals and organizations with an industry outlook.

  • API

    Daily Vehicle Miles of Travel: Beginning 1985

    data.ny.gov | Last Updated 2022-02-15T22:29:27.000Z

    VMT is an estimate of travel based on traffic counts taken along the roads in New York State. Each year travel is estimated as part of the annual report to the Federal Highway Administration through the Highway Performance Monitoring System software application. The VMT estimate is stratified by the roadway Functional Classification of Principal Arterials, Minor Arterials, Collectors, and Local Roads & Street. The VMT data from 1985 through the current year is available.

  • API

    HVAC Market Share by Efficiency and Capacity: Beginning 2017

    data.ny.gov | Last Updated 2022-05-14T14:31:10.000Z

    HVAC Market Share by Efficiency and Capacity: Beginning 2017 dataset is based on heating, ventilation, and air conditioning (HVAC) sales data reported to D+R International by Heating, Air-conditioning & Refrigeration Distributors International (HARDI) members participating in the Unitary HVAC Market Report. Participation in the report is voluntary for distributors. The dataset covers New York State and the Northeast (includes Maine, New Hampshire, Vermont, Massachusetts, Connecticut, and Rhode Island). Blank cells represent data that are not currently available.